Topical propranolol 1% cream for pyogenic granulomas of the nail: open‐label study in 10 patients

References 1 Delsol G, Falini B, Muller-Hermelink HK et al. Anaplastic large cell lymphoma (ALCL) ALK-positive. In Swerdlow SH, Campo E, Harris NL, Jaffe E, Pileri SA, Stein H, Thiele J, Vardiman eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. World health Organization IARC press, Lyon, 2008: 312–316. 2 Kempf W, Willemze R, Jaffe ES, Burg G, Kadin ME. CD30+ T-cell lymphoproliferative disorders. In LeBoit PE, Burg G, Weedon D, Sarasin A eds. Pathology & Genetics – Skin Tumours. World health Organization IARC press, Lyon, 2006: 179–181. 3 Mann KP, Hall B, Kamino H, Borowitz MJ, Ratech H. Neutrophil-rich, Ki-1-positive anaplastic large cell malignant lymphoma. Am J Surg Pathol 1995; 19: 407–416. 4 Burg G, Kempf W, Kazakov DV et al. Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol 2003; 148: 580–586. 5 Garland SM. Imiquimod. Curr Opin Infect Dis 2003; 16: 85–89. 6 David CV, Nguyen H, Goldenberg G. Imiquimod: a review of off-label clinical applications. J Drugs Dermatol 2011; 10: 1300–1306. 7 Didona B, Benucci R, Amerio P, Canzona F, Rienzo O, Cavalieri R. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara). Br J Dermatol 2004; 150: 1198–1201. 8 Coors EA, Schuler G, Von Den Driesch P. Topical imiquimod as treatment for different kinds of cutaneous lymphoma. Eur J Dermatol 2006; 16: 391–393. 9 Ehst BD, Dr eno B, Vonderheid EC. Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream. Eur J Dermatol 2008; 18: 467–468.